デフォルト表紙
市場調査レポート
商品コード
1448481

再生医療市場:動向、予測、競合分析

Regenerative Medicine Market: Trends, Forecast and Competitive Analysis

出版日: | 発行: Lucintel | ページ情報: 英文 150 - page report | 納期: 3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=158.49円

ご注意: DRM (デジタル著作権管理システム) 付PDFになります。
制限内容は、上記ライセンスの[詳細]アイコンをクリックしてご確認ください。

再生医療市場:動向、予測、競合分析
出版日: 2024年02月21日
発行: Lucintel
ページ情報: 英文 150 - page report
納期: 3営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

再生医療市場の動向と予測

世界の再生医療市場は、2030年までに102億米ドルに達すると推定され、2024~2030年のCAGRは3.0%で成長すると予測されています。この市場の主要促進要因は、個別化医療に対する人々の嗜好の高まり、研究開発活動に関する政府や民間機関による投資の増加、幹細胞治療における技術の進歩です。世界の再生医療市場の将来は、筋骨格系疾患、創傷治療、腫瘍学、眼疾患、糖尿病における機会で有望視されています。

再生医療市場の新たな動向

業界の力学に直接的な影響を与える新たな動向としては、幹細胞技術の採用の増加や、組織工学・再生医療における3Dバイオプリンティング技術の利用の増加が挙げられます。

この市場では、細胞ベースの免疫・細胞療法が再生医療の最大の製品であり、筋骨格系疾患が最大の応用セグメントです。再生医療市場の様々なセグメントにおける成長を以下に示す:

本調査では、世界の再生医療市場について、材料別、製品別、用途別、流通チャネル別、地域別の動向と予測を以下のようにまとめた:

材料別[2018~2030年の金額(100万米ドル)出荷分析]:

  • 合成
    • 足場材料
    • 人工血管グラフト材料
    • ハイドロゲル材料
  • 生物由来材料
    • コラーゲン
    • 異種材料
  • 遺伝子組み換え材料
    • デオキシリボ核酸トランスフェクションベクター
    • 遺伝子操作細胞
    • 三次元ポリマー技術
    • トランスジェニック
    • 線維芽細胞
    • 神経幹細胞
    • 遺伝子活性化マトリックス
  • 医薬品
    • 低分子医薬品
    • 生物製剤

製品別[2018~2030年の金額(100万米ドル)出荷分析]:

  • 細胞ベースの免疫療法・細胞療法製品
  • 組織工学製品
  • 低分子・生物製剤
  • 遺伝子治療製品

用途別[2018~2030年の出荷額(100万米ドル)分析]:筋骨格系疾患

  • 筋骨格系疾患
  • 創傷治療
  • 腫瘍学
  • 眼疾患
  • 糖尿病
  • その他

流通チャネル別[2018~2030年の金額(100万米ドル)出荷分析]

  • 病院
  • クリニック
  • その他

地域別[2018~2030年の出荷額(100万米ドル)分析]:北米

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • 英国
    • ドイツ
    • フランス
  • アジア太平洋
    • 中国
    • インド
    • 日本
  • その他
    • ブラジル

再生医療市場洞察

  • Lucintelは、細胞療法製品に関する研究開発活動への政府支援の増加や、再生医療の承認合理化のためのFDAによるCures Actの制定により、細胞ベースの免疫学と細胞療法製品が予測期間中最大のセグメントであり続けると予測しています。
  • この市場の中では、整形外科疾患の増加と高齢者人口の増加により、筋骨格系疾患が予測期間中も最大の用途別セグメントであり続けると考えられます。
  • 北米は、先端技術の存在と新規治療の開発に携わる研究機関の多さから、予測期間中も最大の地域であり続けると考えられます。

よくある質問

Q1.市場規模は:

回答:世界の再生医療市場は、2030年までに102億米ドルに達すると予測されていますが、この市場規模について教えてください。

Q2.市場の成長予測は:

回答:再生医療市場は、2024~2030年にかけてCAGR 3.0%で成長すると予測されています。

Q3.市場の成長に影響を与える主要促進要因は:

A1.この市場の主要促進要因は、個別化医療に対する人々の嗜好の高まり、研究開発活動に関する政府や民間機関による投資の増加、幹細胞治療における技術の進歩です。

Q4.再生医療の主要最終用途は何ですか?

回答:病院やクリニックが再生医療の主要最終用途です。

Q5.再生医療市場の新たな動向は?

回答:業界の力学に直接的な影響を与える新たな動向としては、幹細胞技術の採用の増加や、組織工学・再生医療における3Dバイオプリンティング技術の利用の増加が挙げられます。

Q6.主要な再生医療企業はどこですか?

回答:主要再生医療企業は以下の通りです:

  • Kite Pharma
  • Novartis
  • Vericel
  • Integra LifeSciences
  • Wright Medical
  • MiMedx
  • Osiris Therapeutics
  • Stryker
  • Spark Therapeutics
  • Zimmer Biomet

Q7.今後、再生医療の原料セグメントで最も伸びるセグメントは?

A4.Lucintelでは、細胞治療製品に関連する研究開発活動への政府支援の増加や、再生医療の承認を合理化するためのFDAによるCures Actの制定により、細胞ベースの免疫・細胞治療製品が予測期間中最大のセグメントであり続けると予測しています。

Q8:再生医療市場において、今後5年間で最大となる地域はどこか。

回答:今後5年間も北米が最大です。

Q9.レポートのカスタマイズは可能か:

回答:はい、Lucintelは追加費用なしで10%のカスタマイズを記載しています。

目次

第2章 市場の背景と分類

  • イントロダクション、背景、分類
  • サプライチェーン
  • 業界の促進要因と課題

第3章 2018~2030年の市場動向と予測分析

  • マクロ経済の動向と予測
  • 世界の再生医療市場動向と予測
  • 材料別の世界の再生医療市場
    • 合成
      • 足場
      • 人工血管材料
      • ハイドロゲル材料
    • 生物由来材料
      • コラーゲン
      • 異種材料
    • 遺伝子組み換え材料
      • デオキシリボ核酸トランスフェクションベクター
      • 遺伝子操作された細胞
      • 三次元ポリマー技術
      • トランスジェニックス
      • 線維芽細胞
      • 神経幹細胞
      • 遺伝子活性化マトリックス
    • 医薬品
      • 低分子
      • 生物製剤
  • 製品別の世界の再生医療市場
    • 細胞ベースの免疫療法と細胞療法製品
    • 組織工学的に加工された製品
    • 低分子と生物製剤
    • 遺伝子治療製品
  • 用途別の世界の再生医療市場
    • 筋骨格系疾患
    • 創傷ケア
    • 腫瘍学
    • 眼疾患
    • 糖尿病
    • その他
  • 流通チャネル別の世界の再生医療市場
    • 病院
    • クリニック
    • その他

第4章 地域別の市場動向と予測分析

  • 地域別の世界の再生医療市場
  • 北米の再生医療市場
  • 欧州の再生医療市場
  • アジア太平洋の再生医療市場
  • その他地域の再生医療市場

第5章 競合の分析

  • 市場シェア分析
  • 製品ポートフォリオ分析
  • 運用上の統合
  • 地理的範囲
  • ポーターのファイブフォース分析

第6章 成長機会と戦略的分析

  • 成長機会の分析
    • 材料別の世界の再生医療市場の成長機会
    • 製品別の世界の再生医療市場の成長機会
    • 用途別の世界の再生医療市場の成長機会
    • 流通チャネル別の世界の再生医療市場の成長機会
    • 地域別の世界の再生医療市場の成長機会
  • 世界の再生医療市場における新たな動向
  • 戦略的分析
    • 新製品の開発
    • 世界の再生医療市場の能力拡大
    • 世界の再生医療市場における合併、買収、合弁事業

第7章 有力企業の企業プロファイル

  • Kite Pharma
  • Novartis
  • Vericel Corporation
  • Integra LifeSciences
  • Wright Medical
  • MiMedx
  • Osiris Therapeutics
  • Stryker Corporation
  • Spark Therapeutics
  • Zimmer Biomet Holdings, Inc.
目次

Regenerative Medicine Market Trends and Forecast

The future of the global regenerative medicine market looks promising with opportunities in musculoskeletal disorders, wound care, oncology, ocular disorders, and diabetes. The global regenerative medicine market is expected to reach an estimated $10.2 billion by 2030, and it is forecast to grow at a CAGR of 3.0% from 2024 to 2030. The major drivers for this market are increasing preference of people for personalized medicines, rising investment by governments and private agencies regarding research and development activities, and technological advancements in stem-cell therapies.

Emerging Trends in the Regenerative Medicine Market

Emerging trends, which have a direct impact on the dynamics of the industry, include increasing adoption of stem cell technologies and increasing use of 3D bioprinting technologies in tissue engineering & regenerative medicine.

A total of 94 figures / charts and 87 tables are provided in this more than 184-page report to help in your business decisions. Sample figures with some insights are shown below.

In this market, cell-based immunology & cell therapy is the largest product of regenerative medicine, whereas musculoskeletal disorders is the largest application. Growth in various segments of the regenerative medicine market are given below:

The study includes trends and forecast for the global regenerative medicine market by material, product, application, distribution channel, and region as follows:

By Material [Value ($ Million) shipment analysis for 2018 - 2030]:

  • Synthetic
    • Scaffold
    • Artificial Vascular Graft Materials
    • Hydrogel Materials
  • Biologically Derived Materials
    • Collagen
    • Xenogeneic Materials
  • Genetically Engineered Materials
    • Deoxyribonucleic Acid Transfection Vectors
    • Genetically Manipulated Cells
    • Three-Dimensional Polymer Technology
    • Transgenics
    • Fibroblasts
    • Neural Stem Cells
    • Gene-Activated Matrices
  • Pharmaceuticals
    • Small Molecules
    • Biologics

By Product [Value ($ Million) shipment analysis for 2018 - 2030]:

  • Cell-Based Immunotherapy & Cell Therapy Products
  • Tissue-Engineered Products
  • Small Molecules and Biologics
  • Gene Therapy Products

By Application [Value ($ Million) shipment analysis for 2018 - 2030]:

  • Musculoskeletal Disorders
  • Wound Care
  • Oncology
  • Ocular Disorders
  • Diabetes
  • Other Applications

By Distribution Channel [Value ($ Million) shipment analysis for 2018 - 2030]:

  • Hospitals
  • Clinics
  • Others

By Region [Value ($ Million) shipment analysis for 2018 - 2030]:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • United Kingdom
    • Germany
    • France
  • Asia Pacific
    • China
    • India
    • Japan
  • The Rest of the World
    • Brazil

List of Regenerative Medicine Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies regenerative medicine companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the regenerative medicine companies profiled in this report include.

  • Kite Pharma
  • Novartis
  • Vericel
  • Integra LifeSciences
  • Wright Medical
  • MiMedx
  • Osiris Therapeutics
  • Stryker
  • Spark Therapeutics
  • Zimmer Biomet

Regenerative Medicine Market Insights

  • Lucintel forecasts that cell-based immunology and cell therapy products will remain the largest segment over the forecast period due to increasing government support in research and development activities related to cell therapy products and establishment of the Cures Act by FDA for streamlining the approval of regenerative medicine.
  • Within this market, musculoskeletal disorders will remain the largest segment by application over the forecast period due to increasing orthopedic diseases and rising geriatric population.
  • North America will remain the largest region over the forecast period due to presence of advanced technologies and a large number of research institutes involved in the development of novel therapeutics.

Features of the Regenerative Medicine Market

  • Market Size Estimates: Regenerative medicine market size estimation in terms of value ($M).
  • Trend and Forecast Analysis: Market trends (2018-2023) and forecast (2024-2030) by various segments and regions.
  • Segmentation Analysis: Regenerative medicine market size by various segments, such as material, product, application, and distribution channel.
  • Regional Analysis: Regenerative medicine market breakdown by North America, Europe, Asia Pacific, and the Rest of the World.
  • Growth Opportunities: Analysis on growth opportunities in different material, product, application, distribution channel, and regions for regenerative medicine market.
  • Strategic Analysis: This includes M&A and competitive landscape for the regenerative medicine .
  • Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the regenerative medicine market size?

Answer:The global regenerative medicine market is expected to reach an estimated $10.2 billion by 2030.

Q2. What is the growth forecast for regenerative medicine market?

Answer:The regenerative medicine market is expected to grow at a CAGR of 3.0% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the regenerative medicine market?

Answer: The major drivers for this market are increasing preference of people for personalized medicines, rising investment by governments and private agencies regarding research and development activities, and technological advancements in stem-cell therapies.

Q4. What are the major applications or end use industries for regenerative medicine?

Answer:Hospital and clinic are the major end uses for regenerative medicine

Q5. What are the emerging trends in regenerative medicine market?

Answer:Emerging trends, which have a direct impact on the dynamics of the industry, include increasing adoption of stem cell technologies and increasing use of 3D bioprinting technologies in tissue engineering & regenerative medicine.

Q6. Who are the key regenerative medicine companies?

Answer:Some of the key regenerative medicine companies are as follows:

  • Kite Pharma
  • Novartis
  • Vericel
  • Integra LifeSciences
  • Wright Medical
  • MiMedx
  • Osiris Therapeutics
  • Stryker
  • Spark Therapeutics
  • Zimmer Biomet

Q7.Which regenerative medicine raw material segment will be the largest in future?

Answer: Lucintel forecasts that cell-based immunology and cell therapy products will remain the largest segment over the forecast period due to increasing government support in research and development activities related to cell therapy products and establishment of the Cures Act by FDA for streamlining the approval of regenerative medicine.

Q8: In regenerative medicine market, which region is expected to be the largest in next 5 years?

Answer:North America will remain the largest region in next 5 years.

Q9. Do we receive customization in this report?

Answer:Yes, Lucintel provides 10% Customization Without any Additional Cost.

This report answers following 11 key questions

  • Q.1 What are some of the most promising potential, high-growth opportunities for the global regenerative medicine market by material (synthetic (scaffold, artificial vascular graft materials, and hydrogel materials), biologically derived materials (collagen and xenogeneic materials), genetically engineered materials (deoxyribonucleic acid transfection vectors, genetically manipulated cells, three-dimensional polymer technology, transgenics, fibroblasts, neural stem cells, and gene-activated matrices), and pharmaceuticals (small molecules and biologics)), product (cell-based immunotherapy & cell therapy products, tissue-engineered products, small molecules and biologics, and gene therapy products), application (musculoskeletal disorders, wound care, oncology, ocular disorders, diabetes, and other applications), distribution channel (hospitals, clinics, and others), and region (North America, Europe, Asia Pacific, and Rest of the World)?
  • Q. 2 Which segments will grow at a faster pace and why?
  • Q.3 Which region will grow at a faster pace and why?
  • Q.4 What are the key factors affecting market dynamics? What are the drivers and challenges of the market?
  • Q.5 What are the business risks and threats to the market?
  • Q.6 What are the emerging trends in this market and the reasons behind them?
  • Q.7 What are some changing demands of customers in the market?
  • Q.8 What are the new developments in the market? Which companies are leading these developments?
  • Q.9 Who are the major players in this market? What strategic initiatives are being implemented by key players for business growth?
  • Q.10 What are some of the competitive products and processes in this market, and how big of a threat do they pose for loss of market share via material or product substitution?
  • Q.11 What M & A activities did take place in the last five years in this market?

Table of Contents

2. Market Background and Classifications

  • 2.1 Introduction, Background, and Classifications
  • 2.2 Supply Chain
  • 2.3 Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1 Macroeconomic Trends and Forecast
  • 3.2 Global Regenerative Medicine Market Trends and Forecast
  • 3.3 Global Regenerative Medicine Market by Material
    • 3.3.1 Synthetic
      • 3.3.1.1 Scaffold
      • 3.3.1.2 Artificial Vascular Graft Materials
      • 3.3.1.3 Hydrogel Materials
    • 3.3.2 Biologically Derived Materials
      • 3.3.2.1 Collagen
      • 3.3.2.2 Xenogeneic Materials
    • 3.3.3 Genetically Engineered Materials
      • 3.3.3.1 Deoxyribonucleic Acid Transfection Vectors
      • 3.3.3.2 Genetically Manipulated Cells
      • 3.3.3.3 Three-dimensional Polymer Technology
      • 3.3.3.4 Transgenics
      • 3.3.3.5 Fibroblasts
      • 3.3.3.6 Neural Stem Cells
      • 3.3.3.7 Gene-activated Matrices
    • 3.3.4 Pharmaceuticals
      • 3.3.4.1 Small Molecules
      • 3.3.4.2 Biologics
  • 3.4 Global Regenerative Medicine Market by Product
    • 3.4.1 Cell-Based Immunotherapy & Cell Therapy Products
    • 3.4.2 Tissue-Engineered Products
    • 3.4.3 Small Molecules And Biologics
    • 3.4.4 Gene Therapy Products
  • 3.5 Global Regenerative Medicine Market by Application
    • 3.5.1 Musculoskeletal Disorders
    • 3.5.2 Wound Care
    • 3.5.3 Oncology
    • 3.5.4 Ocular Disorders
    • 3.5.5 Diabetes
    • 3.5.6 Other Applications
  • 3.6 Global Regenerative Medicine Market by Distribution Channel
    • 3.6.1 Hospitals
    • 3.6.2 Clinic
    • 3.6.3 Others

4. Market Trends and Forecast Analysis by Region

  • 4.1 Global Regenerative Medicine Market by Region
  • 4.2 North American Regenerative Medicine Market
    • 4.2.1 Market by Material: Synthetic (Scaffold, Artificial Vascular Graft Materials, and Hydrogel Materials), Biologically Derived Materials (Collagen and Xenogeneic Materials), Genetically Engineered Materials (Deoxyribonucleic Acid Transfection Vectors, Genetically Manipulated Cells, Three-dimensional Polymer Technology, Transgenics, Fibroblasts, Neural Stem Cells, and Gene-activated Matrices), Pharmaceuticals (Small Molecules and Biologics)
    • 4.2.2 Market by Product: Cell-Based Immunotherapy & Cell Therapy Products, Tissue-Engineered Products, Small Molecules and Biologics, and Gene Therapy Products
    • 4.2.3 Market by Application: Musculoskeletal Disorders, Wound Care, Oncology, Ocular Disorders, Diabetes, and Other Applications
    • 4.2.4 Market by Distribution Channel: Hospitals, Clinics, and Others
    • 4.2.5 The United States Regenerative Medicine Market
    • 4.2.6 The Canadian Regenerative Medicine Market
    • 4.2.7 The Mexican Regenerative Medicine Market
  • 4.3 European Regenerative Medicine Market
    • 4.3.1 Market by Material: Synthetic (Scaffold, Artificial Vascular Graft Materials, and Hydrogel Materials), Biologically Derived Materials (Collagen and Xenogeneic Materials), Genetically Engineered Materials (Deoxyribonucleic Acid Transfection Vectors, Genetically Manipulated Cells, Three-dimensional Polymer Technology, Transgenics, Fibroblasts, Neural Stem Cells, and Gene-activated Matrices), Pharmaceuticals (Small Molecules and Biologics)
    • 4.3.2 Market by Product: Cell-Based Immunotherapy & Cell Therapy Products, Tissue-Engineered Products, Small Molecules and Biologics, and Gene Therapy Products
    • 4.3.3 Market by Application: Musculoskeletal Disorders, Wound Care, Oncology, Ocular Disorders, Diabetes, and Other Applications
    • 4.3.4 Market by Distribution Channel: Hospitals, Clinics, and Others
    • 4.3.5 The Regenerative Medicine Market of the United Kingdom
    • 4.3.6 The German Regenerative Medicine Market
    • 4.3.7 The French Regenerative Medicine Market
  • 4.4 APAC Regenerative Medicine Market
    • 4.4.1 Market by Material: Synthetic (Scaffold, Artificial Vascular Graft Materials, and Hydrogel Materials), Biologically Derived Materials (Collagen and Xenogeneic Materials), Genetically Engineered Materials (Deoxyribonucleic Acid Transfection Vectors, Genetically Manipulated Cells, Three-dimensional Polymer Technology, Transgenics, Fibroblasts, Neural Stem Cells, and Gene-activated Matrices), Pharmaceuticals (Small Molecules and Biologics)
    • 4.4.2 Market by Product: Cell-Based Immunotherapy & Cell Therapy Products, Tissue-Engineered Products, Small Molecules and Biologics, and Gene Therapy Products
    • 4.4.3 Market by Application: Musculoskeletal Disorders, Wound Care, Oncology, Ocular Disorders, Diabetes, and Other Applications
    • 4.4.4 Market by Distribution Channel: Hospitals, Clinics, and Others
    • 4.4.5 The Chinese Regenerative Medicine Market
    • 4.4.6 The Indian Regenerative Medicine Market
    • 4.4.7 The Japanese Regenerative Medicine Market
  • 4.5 ROW Regenerative Medicine Market
    • 4.5.1 Market by Material: Synthetic (Scaffold, Artificial Vascular Graft Materials, and Hydrogel Materials), Biologically Derived Materials (Collagen and Xenogeneic Materials), Genetically Engineered Materials (Deoxyribonucleic Acid Transfection Vectors, Genetically Manipulated Cells, Three-dimensional Polymer Technology, Transgenics, Fibroblasts, Neural Stem Cells, and Gene-activated Matrices), Pharmaceuticals (Small Molecules and Biologics)
    • 4.5.2 Market by Product: Cell-Based Immunotherapy & Cell Therapy Products, Tissue-Engineered Products, Small Molecules and Biologics, and Gene Therapy Products
    • 4.5.3 Market by Application: Musculoskeletal Disorders, Wound Care, Oncology, Ocular Disorders, Diabetes, and Other Applications
    • 4.5.4 Market by Distribution Channel: Hospitals, Clinics, and Others
    • 4.5.5 Brazilian Regenerative Medicine Market

5. Competitor Analysis

  • 5.1 Market Share Analysis
  • 5.2 Product Portfolio Analysis
  • 5.3 Operational Integration
  • 5.4 Geographical Reach
  • 5.5 Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1 Growth Opportunity Analysis
    • 6.1.1 Growth Opportunities for the Global Regenerative Medicine Market by Material
    • 6.1.2 Growth Opportunities for the Global Regenerative Medicine Market by Product
    • 6.1.3 Growth Opportunities for the Global Regenerative Medicine Market by Application
    • 6.1.4 Growth Opportunities for the Global Regenerative Medicine Market by Distribution Channel
    • 6.1.5 Growth Opportunities for the Global Regenerative Medicine Market by Region
  • 6.2 Emerging Trends in the Global Regenerative Medicine Market
  • 6.3 Strategic Analysis
    • 6.3.1 New Product Development
    • 6.3.2 Capacity Expansion of the Global Regenerative Medicine Market
    • 6.3.3 Mergers, Acquisitions, and Joint Ventures in the Global Regenerative Medicine Market

7. Company Profiles of Leading Players

  • 7.1 Kite Pharma
  • 7.2 Novartis
  • 7.3 Vericel Corporation
  • 7.4 Integra LifeSciences
  • 7.5 Wright Medical
  • 7.6 MiMedx
  • 7.7 Osiris Therapeutics
  • 7.8 Stryker Corporation
  • 7.9 Spark Therapeutics
  • 7.10 Zimmer Biomet Holdings, Inc.